Division of Endocrinology, Department of Medicine, Austin Health, University of Melbourne, Melbourne, Australia.
Endocrinol Metab (Seoul). 2015 Dec;30(4):419-28. doi: 10.3803/EnM.2015.30.4.419. Epub 2015 Sep 22.
Vertebral fractures and trabecular bone loss have dominated thinking and research into the pathogenesis and the structural basis of bone fragility during the last 70 years. However, 80% of all fractures are non-vertebral and occur at regions assembled using large amounts of cortical bone; only 20% of fractures are vertebral. Moreover, ~80% of the skeleton is cortical and ~70% of all bone loss is cortical even though trabecular bone is lost more rapidly than cortical bone. Bone is lost because remodelling becomes unbalanced after midlife. Most cortical bone loss occurs by intracortical, not endocortical remodelling. Each remodelling event removes more bone than deposited enlarging existing canals which eventually coalesce eroding and thinning the cortex from 'within.' Thus, there is a need to study the decay of cortical as well as trabecular bone, and to develop drugs that restore the strength of both types of bone. It is now possible to accurately quantify cortical porosity and trabecular decay in vivo. The challenges still to be met are to determine whether measurement of porosity identifies persons at risk for fracture, whether this approach is compliments information obtained using bone densitometry, and whether changes in cortical porosity and other microstructural traits have the sensitivity to serve as surrogates of treatment success or failure.
在过去的 70 年中,脊柱骨折和小梁骨丢失一直主导着人们对骨脆性的发病机制和结构基础的思考和研究。然而,80%的骨折是非脊柱性的,发生在大量皮质骨组装的区域;只有 20%的骨折是脊柱性的。此外,80%的骨骼是皮质骨,尽管小梁骨的丢失速度比皮质骨快,但约 70%的骨丢失是皮质骨。骨丢失是因为中年后重塑变得不平衡。大多数皮质骨丢失是通过皮质内而不是内皮质重塑发生的。每个重塑事件都会去除比沉积更多的骨,从而扩大现有的管腔,最终融合侵蚀并从“内部”使皮质变薄。因此,有必要研究皮质和小梁骨的衰变,并开发恢复这两种类型骨强度的药物。现在已经可以准确地定量活体皮质的孔隙率和小梁骨的衰减。仍然需要解决的挑战是确定孔隙率的测量是否可以识别骨折风险人群,这种方法是否可以补充使用骨密度仪获得的信息,以及皮质孔隙率和其他微观结构特征的变化是否具有作为治疗成功或失败替代指标的敏感性。